Screener
Eligibility screening
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
8 US sites in AZ, CA, IL, MI +4
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
8 US sites in AZ, CA, IL, MI +4
Before we begin
Your answer affects how the questions are phrased.